RxDoctor Payments Data

Thomas Eng, DO

Family Medicine · Geneva, ILNPI 1639277551

Payments from drug & device makers

$2,053in general payments, 2019–2025

Across 17 payments — averaging $120.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$830
  • Treace Medical Concepts, Inc.$506
  • Solventum Corporation$377
  • Acera Surgical, Inc.$153
  • Johnson & Johnson$92
  • Medela LLC$79
  • plus $18 from 1 others

What the payments were for

  • Food & beverage$2,053100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,053 in reported general payments places this provider in the 80th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$118,879
Medicare patients
421
Services billed
4,377

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin33$46,401
JanuviaSitagliptin Phosphate35$43,423
EliquisApixaban41$37,663
FarxigaDapagliflozin Propanediol25$31,554
OzempicSemaglutide25$23,056
XareltoRivaroxaban12$16,079
MyrbetriqMirabegron16$10,995
RestasisCyclosporine13$8,525
Butalb-Acetaminoph-Caff-CodeinButalbit/Acetamin/Caff/Codeine26$5,984
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate25$3,769
Atorvastatin Calcium384$3,465
SymbicortBudesonide/Formoterol Fumarate14$3,374
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen154$3,242
Tamsulosin Hcl161$3,128
Levothyroxine Sodium281$2,912

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$92$16,07912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Geneva

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →